Methanogens, methane and gastrointestinal motility

Journal of Neurogastroenterology and Motility

Volumn 20, Issue 1, 2014, Pages 31-40

  Triantafyllou, Konstantinos ^a,b   Chang, Christopher ^a   Pimentel, Mark ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Constipation; Gastroparesis; Irritable bowel syndrome; Methane; Methanococcus

Indexed keywords

CARBOHYDRATE; HYDROGEN; METHANE; POLYSACCHARIDE;

ANAEROBIC FERMENTATION; ANTIBIOTIC THERAPY; BREATH ANALYSIS; BREATHING; CHRONIC DISEASE; CONSTIPATION; DISEASE ASSOCIATION; FLATULENCE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HUMAN; INTESTINE MOTILITY; IRRITABLE COLON; METHANOGEN; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PHYSIOLOGICAL PROCESS; REVIEW; STOMACH PARESIS;

EID: 84891689653     PISSN: 20930879     EISSN: 20930887     Source Type: Journal    
DOI: 10.5056/jnm.2014.20.1.31     Document Type: Review

References (81)

1. Chassard C, Lacroix C. Carbohydrates and the human gut microbiota. Curr Opin Clin Nutr Metab Care 2013;16:453-460.
2. de Lacy Costello BPJ, Ledochowski M, Ratcliffe NM. The importance of breath testing: a review. J Breath Res 2013;7:024001.
3. Eckard RJ, Grainger C, de Klein CAM. Options for abatement of methane and nitrous oxide from ruminant production: A review. Livest Sci 2010;130:47-56.
4. Sahakian AB, Jee SR, Pimentel M. Methane and the gastrointestinal tract. Dig Dis Sci 2010;55:2134-2143.
5. Roccarina D, Lauritano EC, Gabrielli M, Franceschi F, Ojetti V, Gasbarrini A. The role of methane in intestinal diseases. Am J Gastroenterol 2010;1250-1256.
6. Mathur R, Amichai M, Chua KS, Mirocha J, Barlow GM, Pimentel M. Methane and hydrogen positivity on breath test is associated with greater body mass index and body fat. J Clin Endocrinol Metab 2013;98:E698-E702.
7. Jones WJ, Nagle DP Jr, Whitman WB. Methanogens and the diversity of the archaebcteria. Microbiol Rev 1987;51:135-177.
8. Forterre P, Brochier C, Philippe H. Evolution of the archaea. Theor Popul Biol 2002;61:409-422.
9. Khelaifia S, Raoult D, Drancourt M. A versatile medium for cultivating methanogenic archaea. PLoS One 2013;8:e61563.
10. Khelaifia S, Drancourt M. Susceptibility of archaea to antimicrobial agents: applications to clinical microbiology. Clin Microbiol Infect 2012;18:841-848.
11. Scanlan PD, Shanahan F, Marchesi J. Human methanogen diversity and incidence in healthy and diseased colonic groups using mrcA gene analysis. BMC Microbiol 2008;8:79.
12. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635-1638.
13. Lepp PW, Bring MM, Ouverney CC, Palm K, Armitage GC, Relman DA. Methanogenic archaea and human periodontal disease. Proc Natl Acad Sci USA 2004;101:6176-6181.
14. Nam YD, Chang HW, Kim KH, et al. Bacterial, archaeal and eukaryal diversity in intestines of Korean people. J Microbiol 2008; 46:491-501.
15. Miller TL, Wolin MJ. Enumeration of Methanobrevibacter smithii in human feces. Arch Microbiol 1982;131:14-18.
16. Pochart P, Lémann F, Flourié B, Pellier P, Goderel I, Rambaud JC. Pyxigraphic sampling to enumerate methanogens and anaerobes in the right colon of healthy humans. Gastroenterology 1993;105:1281-1285.
17. Matarazzo F, Ribeiro AC, Faveri M, Taddei C, Martinez MB, Mayer MP. The domain Archaea in human mucosal surfaces. Clin Microbiol Infect 2012;18:834-840.
18. Dridi B, Henry M, El Khéchine A, Raoult D, Drancourt M. High prevelance of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS ONE 2009;4:e7063.
19. Palmer C, Bik EM, Di Giulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007;5:e177.
20. Koenig JE, Spor A, Scalfone N, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 2011;108(suppl 1):4578-4585.
21. Neu J, Rushing J. Cesarean versus vaginal delivery: long term infant outcomes and the hygiene hypothesis. Clin Perinatol 2011;38:321-331.
22. Bond JH Jr, Engel RR, Levitt MD. Factors influencing pulmonary methane excretion in man. J Exp Med 1971;133:572-588.
23. Florin TH, Zhu G, Kirk KM, Martin NG. Shared and unique environmental factors determine the ecology of methanogens in humans and rats. Am J Gastroenterol 2000;95:2872-2879.
24. Flourié B, Etanchaud F, Florent C, Pellier P, Bouhnik Y, Rambaud JC. Comparative study of hydrogen and methane production in the human colon using caecal and faecal homogenates. Gut 1990;31:684-685.
25. Kim G, Giamarellos-Bourboulis EJ, Pyleris E, et al. Methanobrevibacter Smithii is found in human duodenum and is associated with altered luminal cytokines. Gastroenterology 2012;142:S-98.
26. McKay LF, Holbrook WP, Eastwood MA. Methane and hydrogen production by human intestinal anaerobic bacteria. Acta Microbopl Immunol Scand B 1982;90:257-260.
27. Blaut M. Metabolism of methanogens. Antoine Van Leeuwenhoek 1994;66:187-208.
28. Christl SU, Gibson GR, Cummings JH. Role of dietary sulphate in the regulation of methanogenesis in the human large intestine. Gut 1992;33:1234-1238.
29. Christl SU, Murgatroyd PR, Gibson GR, Cummings JH. Production, metabolism and excretion of hydrogen in the large intestine. Gastroenterology 2000;102(4 Pt 1):1269-1277.
30. Cloarec D, Bornet F, Gouilloud S, Barry JL, Salim B, Galmiche JP. Breath hydrogen response to lactulose in healthy subjects: relationship to methane production status. Gut 1990;31:300-304.
31. Levitt MD, Furne JK, Kuskowski M, Ruddy J. Stability of human methanogenic flora over 35 years and a review of insights obtained from breath methane measurements. Clin Gastroenterol Hepatol 2006;4:123-129.
32. Pimentel M, Mayer AG, Park S, Chow EJ, Hasan A, Kong Y. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci 2003;48:86-92.
33. Hwang L, Low K, Khoshini R, et al. Evaluating breath methane as a diagnostic test for constipation-predominant IBS. Dig Dis Sci 2010; 55:398-403.
34. Kim EJ, Paik CN, Chung WC, Lee KM, Yang JM, Choi MG. The characteristics of the positivity to the lactulose breath test in patients with abdominal bloating. Eur J Gastroenterol Hepatol 2011;23:1144-1149.
35. Weaver GA, Krause JA, Miller TL, Wolin MJ. Incidence of methanogenic bacteria in a sigmoidoscopy population: an association of methanogenic bacteria and diverticulitis. Gut 1986;27:698-704.
36. McKay LF, Eastwood MA, Brydon WG. Methane excretion in man-a study of breath, flatus and faeces. Gut 1985;26:69-74.
37. Hudson MJ, Tomkins AM, Wiggins HS, Drasar BS. Breath methane excretion and intestinal methanogenesis in children and adults in rural Nigeria. Scand J Gastroenterol 1993;28:993-998.
38. O'Keefe SJ, O'Keefe EA, Burke E, Roberts P, Lavender R, Kemp T. Milk-induced malabsorption in malnourished African patients. Am J Clin Nutr 1991;54:130-135.
39. Bjorneklett A, Jenssen E. relationship between hydrogen (H2) and methane (CH4) production in man. Scand J Gastroenterol 1982;17: 985-992.
40. Melcher EA, Levitt MD, Slavin JL. Methane production and bowel function parameters in healthy subjects on low- and high-fiber diets. Nutr Cancer 1991;16:85-92.
41. Montes PG, Saavedra JM, Perman JA. Relationship between methane production and breath hydrogen excretion in lactose-malabsorbing individuals. Dig Dis Sci 1993;38:445-448.
42. Flatz G, Czeizel A, Métneki J, Flatz SD, Kühnau W, Jahn D. Pulmonary hydrogen and methane excretion following ingestion of an unabsorbable carbohydrate: a study of twins. J Pediatr Gastroenterol Nutr 1985;4:936-941.
43. Mello CS, Tahan S, Melli LC, et al. Methane production and small intestinal bacterial overgrowth in children living in a slum. World J Gastroenterol 2012;18:5932-5939.
44. Heins A, Metz G, Dilawari J, Blendis L, Wiggins H. Breath-methane in patients with cancer of the large bowel. Lancet 1997;2:481-483.
45. Jang SI, Kim JH, Youn YH, Park H, Lee SI, Conklin JL. Relationship between intestinal gas and development of right colon diverticula. J Neurogastroenterol Motil 2010;16:418-423.
46. Kunkel D, Basseri RJ, Makhani MD, Chong K, Chang C, Pimentel M. Methane on breath testing is associated with constipation: a systematic review and meta-analysis. Dig Dis Sci 2011;56:1612-1618.
47. Kim G, Deepinder F, Morales W, et al. Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath. Dig Dis Sci 2012;57:3213-3218.
48. Pimentel M, Lin HC, Enayati P, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol 2006; 290:G1089-G1095.
49. Jahng J, Jung IS, Choi EJ, Concklin JL, Park H. The effects of methane and hydrogen gases produced by enteric bacteria on ileal motility and colonic transit time. Neurogastroenterol Motil 2012;24:185-190, e92.
50. Rao SS, Camilleri M, Hasler WL, et al. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil 2011;23:8-23.
51. Chatterjee S, Park S, Low K, Kong Y, Pimentel M. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol 2007;102:837-841.
52. Rumessen JJ, Nordgaard-Andersen I, Gudmand-Høyer E. Carbohydrate malabsorption: quantification by methane and hydrogen breath tests. Scand J Gastroenterol 1994;29:826-832.
53. Stephen AM, Wiggins HS, Englyst HN, Cole TJ, Wayman BJ, Cummings JH. The effect of age, sex and level of intake of dietary fiber from wheat on large-bowel function in thirty healthy subjects. Br J Nutr 1986;56:349-361.
54. El Oufir L, Flourié B, Bruley des Varannes S, et al. Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans. Gut 1996;38:870-877.
55. Morken MH, Berstad AE, Nysaeter G, Berstad A. Intestinal gas in plain abdominal radiographs does not correlate with symptoms after lactulose challenge. Eur J Gastroenterol Hepatol 2007;19:589-593.
56. Grover M, Kanazawa M, Palsson OS, et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress. Neurogastroenterol Motil 2008;20:998-1008.
57. Attaluri A, Jackson M, Valestin J, Rao SSC. Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol 2010;105:1407-1411.
58. Lee KM, Paik CN, Chung WC, Yang JM, Choi MG. Breath methane positivity is more common and higher in patients with objectively proven delayed transit constipation. Eur J Gastroenterol Hepatol 2013;25:726-732.
59. Pimentel M, Kong Y, Park S. IBS subjects with methane on lactulose breath test have lower postprandial serotonin levels than subjects with hydrogen. Dig Dis Sci 2004;49:84-87.
60. Rana SV, Sharma S, Sinha SK, Kaur H, Sikander A, Singh K. Incidence of predominant methanogenic flora in irritable bowel syndrome patients and apparently healthy controls from north India. Dig Dis Sci 2009;54:132-135.
61. Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol 2008;103:958-963.
62. Peled Y, Weinberg D, Hallak A, Gilat T. Factors affecting methane production in humans. Gastrointestinal diseases and alterations of colonic flora. Dig Dis Sci 1987;32:267-271.
63. Majewski M, McCallum RW. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial. Adv Med Sci 2007;52:139-142.
64. Reddymasu SC, Sotarich S, McCallum RW. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterology 2010;10:23.
65. Lee KN, Lee OY, Koh DH, et al. Association between symptoms of irritable bowel syndrome and methane and hydrogen on lactulose breath test. J Korean Med Sci 2013;28:901-907.
66. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390.
67. Makhani M, Yang J, Mirocha J, Low K, Pimentel M. Factor analysis demonstrates a symptom cluster related to methane and non-methane production in irritable bowel syndrome. J Clin Gastroenterol 2011;45:40-44.
68. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptoms improvement in irritable bowel syndrome: a double blind, randomized, placebo controlled study. Am J Gastroenterol 2003;98:412-419.
69. Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006; 145:557-563.
70. Sharara AI, Aoun E, Abdul-Baki H, Mounzer R, Sidani S, Elhajj I. A randomized double blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol 2006;101:326-333.
71. Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011;364:22-32.
72. Lembo A, Zakko SF, Ferreira NL, et al. Rifaximin for the treatment of diarrhea predominant irritable bowel syndrome: short term treatment leading to long term sustained response. Gastroenterology 2008;134(suppl 1):A545.
73. Pimentel M, Chatterjee S, Chow EJ, Park S, Kong Y. Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study. Dig Dis Sci 2006;51:1297-1301.
74. Low K, Hwang L, Hua J, Zhu A, Morales W, Pimentel M. A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome with methane on lactulose breath test. J Clin Gastroenterol 2010;44:547-550.
75. Shekhar C, Monaghan PJ, Morris J, et al. Rome III Functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology 2013;145:749-757.
76. Furnari M, Savarino E, Buzzone L, et al. Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. J Gastrointestin liver Dis 2012;21:157-163.
77. Ghoshal UC, Srivastava D, Verma A, Misra A. slow transit constipation associated with excess methane production and its improvement following rifaximin therapy. J Neurogastroenterol Motil 2011;17:185-188.
78. Belkind-Gerson J, Kuo B. Gastroparesis: a comprehensive review. Ann Gastroenterol Hepatol 2011;2:1-11.
79. Khayyam U, Sachdeva P, Gomez J, et al. Assessment of symptoms during gastric emptying scintigraphy to correlate symptoms to delayed gastric emptying. Neurogastrointest Motil 2010;22:539-545.
80. Reddymasu SC, McCallum RW. Small intestinal bacterial overgrowth in gastroparesis: are there any predictors? J Clin Gastroenterol 2010;44:e8-e13.
81. George NS, Sankineni A, Parkman HP. Small intestinal overgrowth in gastroparesis. Dig Dis Sci Published Online First: 5 Oct 2012. doi: 10.1007/s10620-012-2426-7